EQT introduces the EQT Healthcare Growth Strategy, a dedicated healthcare buyout strategy, with the acquisition of life sciences tools company Mabtech

EQT Sweden

The new EQT Healthcare Growth Strategy builds on EQT's 30-year healthcare track record and will focus on scaling innovative, fast-growing healthcare companies to help deliver positive outcomes across the value chain           By helping companies build commercial muscle and expand their global reach, the Strategy aims to enable the development of medical research, diagnostics, tools and treatments to deliver more effective, efficient and accessible healthcare           Mabtech is a leading provider of high-quality antibody tools and kits, used predominantly for vaccine, infectious diseases, and oncology research, based in Sweden. EQT Healthcare Growth will support Mabtech as it expands its product portfolio and reach, especially in the USView original content:https://www.prnewswire.co.uk/news-releases/eqt-introduces-the-eqt-healthcare-growth-strategy-a-dedicated-healthcare-buyout-strategy-with-the-acquisition-of-life-sciences-tools-company-mabtech-302029405.html